
Multimodal imaging for a theranostic approach in a murine model of B-cell lymphoma with engineered nanoparticles
Keywords: Mouse model; Preclinical imaging; Theranostic; Fluorescence imaging; Magnetic resonance; Engineered nanoparticles; HA; Hyaluronic acid; NPs; nanoparticles; Ig-BCR; immunoglobulin B-cell receptor; pA20-36; peptide A20-36; pCNT; scrambled or control peptide